表紙
市場調查報告書
商品編碼
971226

胃腸消化健康市場

Gastrointestinals & Health Through Digestion

出版日期: | 出版商: Nicholas Hall & Company | 英文 | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

截至2020年中的12個月中,全球胃腸道和益生菌市場增長了3.6%,達到約220億美元。到2029年,市場規模預計將超過330億美元。這是由於現代生活方式(通常以不規則和不健康的飲食習慣和增加的酒精攝入為特徵),消費者對消化狀態,主要的發射活動和益生菌的瞭解增加,受到健康益處和廣泛接受的推動。

但是,每個市場和類別中的成分限制,與自有品牌和仿製藥的競爭以及某些成熟類別中缺乏創新是市場上的一些限制。

另一方面,消化健康是消費者保健中最熱門的話題之一。腸道菌群對於維持人體的自然防禦能力和改善整體健康至關重要。許多產品(主要是益生菌,益生元和合生元)提供了與消化有關的腸道健康相關益處,例如免疫力,體重管理,情緒和壓力以及皮膚健康。此外,正在進行的腸腦軸研究為腸道菌群在健康中的作用日益擴大提供了新的思路。

本報告調查了胃腸道和消化健康市場,包括市場規模和趨勢,銷售預測,增長因素,法規,頂線銷售,品牌績效,新開發/發佈,競爭狀況,主要內容,提供公司等信息。個人資料。

目錄

執行摘要

  • 世界概況
  • 競爭形勢
  • 類別評論
  • 消化系統健康
  • 展望

巴西

  • 概述
  • 抗酸劑
  • 防脹氣
  • 瀉藥
  • 止瀉藥
  • 消化□
  • 肝臟和膽汁的治療
  • 解痙藥和IBS治療
  • 其他地理標誌
  • 益生菌
  • 展望

中國

法國

德國

印度

意大利

日本

墨西哥

俄羅斯

美國

每個市場概述

  • 加拿大
  • 波蘭
  • 韓國
  • 英國

品牌案例研究

  • Biostime
  • Dulcolax
  • Gaviscon
  • Pedialyte
  • Tums

展望與預測

目錄

Gastrointestinals, Probiotics & the Evolving Market for Health Through Digestion

KEY FEATURES OF THIS REPORT:

  • An in-depth exploration of the GIs and Probiotics market globally, including Antacids, Laxatives, Antidiarrhoeals, Liver & bile remedies, Digestive enzymes, Probiotics and more
  • Coverage of 10 major markets from around the world, with topline sales, brand performances, new developments, launches and promotional campaigns PLUS mini-profiles of additional markets
  • Very latest mid-year 2020 sales from DB6 , our dedicated CHC sales database, plus historical growth rates back to 2015
  • Case studies of key brands , highlighting strategies and success factors, sales, NPD activity and consumer & HCP promotion
  • Forecast sales to 2020 & 2021 for all categories and countries, plus longer-term predictions to 2024 & 2029

The global market for Gastrointestinals plus Probiotics expanded by 3.6% in the 12 months to mid-2020 to nearly $22bn; it is set to be worth over $33bn by 2029. It is being driven by modern lifestyles (often characterised by irregular unhealthy eating patterns and increased alcohol intake), rising consumer understanding of digestive conditions, limited but important launch activity, and wider acceptance of the health benefits of probiotics. Holding back growth are ingredient restrictions in selected markets and categories, brands facing competition from private labels & generics, and a lack of innovation in certain mature categories.

Health Through Digestion is one of the hottest topics in consumer healthcare. The gut microbiome is of central importance in maintaining the body's natural defences and boosting overall wellness. A host of products, primarily probiotics, prebiotics and synbiotics, offer gut health-related benefits beyond digestion such as immunity, weight management, mood & stress, skin health, and more. Ongoing research into the gut-brain axis (the biochemical signal between GI tract and central nervous system) casts fresh light on the expanding role of gut flora in health.

Key questions investigated in this report:

  • How do markets differ in terms of growth drivers, regulations and competitive landscape?
  • Which marketers and brands are performing best and what can be learned from their success?
  • What are the best examples of recent NPD and which developments will help expand the market in future?
  • How have sales been affected by the Covid-19 pandemic?
  • What are the latest findings related to Health through digestion?
  • Do gaps in the market still exist and who is best placed to seize future opportunities?

Covering all the issues affecting the GIs and Probiotics market, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report spans 10 in-depth country profiles (generating over 70% of global sales between them) with insights and predictions, plus mini-profiles of additional markets .

New product developments are explored across markets, including Rx-to-OTC switches, delivery format innovations, line extensions, new benefits and more.

As part of the global overview, this report digs into the latest trends & developments in Health through digestion , including food intolerance and adult & infant nutrition.

Categories covered in this report:

  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Digestive enzymes
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Traditional digestive remedies
  • Other GIs
  • Probiotics

selected markets only.

Brand case studies evaluate the key lessons to be learned from top brands, including consumer messaging, line extensions, portfolio development and brand strategies.

The report features the latest sales data from our dedicated DB6 database, including topline historical sales by region, country and category, and individual brand performances. Sales cover 12 months to mid-year 2020 (and mid-2019), plus historical growth rates back to 2015. The latest short-term forecasts to 2020 & 2021 and longer-term forecasts to 2024 & 2029 for each market and category are included.

Segmentation of sales in selected categories, including antacids, laxatives and probiotics, helps give a more detailed picture of each market.

10 individual markets covered:

  • Brazil
  • China
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Mexico
  • Russia
  • USA

PLUS coverage of selected additional markets in brief.

Table of Contents

Executive Summary

  • Global overview
  • Competitive landscape
  • Category review
  • Health through digestion
  • Outlook

Brazil

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Digestive enzymes
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Other GIs
  • Probiotics
  • Outlook

China

  • Overview
  • Antacids
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Digestive enzymes
  • Liver & bile remedies
  • Other GIs
  • Probiotics
  • Outlook

France

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Other GIs
  • Probiotics
  • Outlook

Germany

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Digestive enzymes
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Other GIs
  • Probiotics
  • Outlook

India

  • Overview
  • Antacids
  • Laxatives
  • Antidiarrhoeals
  • Liver & bile remedies
  • Traditional digestive remedies
  • Probiotics
  • Outlook

Italy

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Probiotics
  • Outlook

Japan

  • Overview
  • Antacids
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Antispasmodics & IBS remedies
  • Traditional digestive remedies
  • Probiotics
  • Outlook

Mexico

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Digestive enzymes
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Other GIs
  • Probiotics
  • Outlook

Russia

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Digestive enzymes
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Other GIs
  • Probiotics
  • Outlook

USA

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Digestive enzymes
  • Liver & bile remedies
  • Other GIs
  • Probiotics
  • Outlook

Selected markets in brief

  • Canada
  • Poland
  • South Korea
  • UK

Brand Case Studies

  • Biostime
  • Dulcolax
  • Gaviscon
  • Pedialyte
  • Tums

Outlook & Prospects